GRTS Deadline: GRTS Investors Have Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Gritstone bio, Inc. securities during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Gritstone securities between March 9, 2023, and February 29, 2024, may be eligible for compensation through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by August 6, 2024 [2]. Group 2: Allegations Against Gritstone - The lawsuit alleges that Gritstone made false and misleading statements regarding its ability to launch the Phase 2b CORAL Study for its COVID-19 vaccine candidate [3]. - It is claimed that Gritstone's inability to launch the study as represented would hinder its ability to secure external funding, negatively impacting its financial stability [3]. - The lawsuit asserts that Gritstone overstated its capacity to develop and commercialize its products, leading to materially false public statements [3].